110
Damora Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
63.9
FY23:
36.8
FY24:
16.8
FY25:
260
(positive)
Change from FY21 to FY25
millions USD
FY21:
12.1
FY22:
9.28
FY23:
1.45
FY24:
0.29
FY25:
0.10
Total assets
Change from FY21 to FY25
millions USD
FY21:
122
FY22:
73.2
FY23:
38.2
FY24:
17.1
FY25:
261
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
4.54
FY22:
11.1
FY23:
5.83
FY24:
1.20
FY25:
20.1
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.45
FY22:
0.33
FY23:
0.07
FY24:
0.10
FY25:
0.08
(positive)
Change from FY21 to FY25
millions USD
FY21:
117
FY22:
61.8
FY23:
32.3
FY24:
15.8
FY25:
240
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
122
FY22:
73.2
FY23:
38.2
FY24:
17.1
FY25:
261
All amounts in millions USD